Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1704 (LINC01704) is a human long non-coding RNA, encoded on chromosome 1, which does not translate into a protein[1][3][7]. There is very limited published functional research on this specific transcript; LINC01704 belongs to the large family of long intergenic non-coding RNAs (lincRNAs), molecules increasingly recognized for their roles in gene regulation, epigenetic modifications, and association with disease, particularly cancer[11]. While the lincRNA family is considered important in cancer progression, diagnosis, and prognosis, there is currently no evidence to suggest that LINC01704 itself is a direct therapeutic target, biomarker, or subject to drug intervention[1][5][7][9]. Its functional characterization, interaction profile, and disease roles remain unestablished in the biomedical literature.
Not applicable; no known drugs or direct targeting mechanism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1704 (LINC01704).